Table
of Contents
|
|
|
|
Preface to the Fourth Edition |
ix |
1 |
Maxillofacial Complications in Systemic Conditions |
1 |
1.1 |
Cardiovascular Disease |
3 |
|
Angina Pectoris |
3 |
|
Angiomas |
3 |
|
Anticoagulants |
3 |
|
Congenital Heart Disease |
3 |
|
Drugs |
3 |
|
Giant Cell Arteritis |
4 |
|
Hereditary Haemorrhagic Telangiectasia
(HHT) |
4 |
|
Hypertension |
4 |
|
Polyarteritis Nodosa |
4 |
|
Transplantation |
5 |
|
Wegener Granulomatosis |
5 |
|
Williams Syndrome |
5 |
|
Further Reading |
6 |
1.2 |
Endocrinological and Metabolic Conditions |
7 |
|
Addison Disease |
7 |
|
Congenital Hypoparathyroidism |
7 |
|
Congenital Hypothyroidism |
7 |
|
Cushing Syndrome |
7 |
|
Diabetes Insipidus |
7 |
|
Diabetes Mellitus |
7 |
|
Gigantism/Acromegaly |
8 |
|
Hyperparathyroidism |
8 |
|
Hyperthyroidism |
10 |
|
Hypothyroidism |
10 |
|
Multiple Endocrine Neoplasia (Adenoma) (Men or Mea) Syndromes |
10 |
|
Pituitary Dwarfism |
11 |
|
Precocious Puberty |
11 |
|
Pregnancy |
11 |
|
Preterm Children |
12 |
|
Metabolic Disorders |
14 |
|
Further Reading |
14 |
1.3 |
Gastrointestinal and Pancreatic Disorders |
16 |
|
Chronic Pancreatitis |
16 |
|
Coeliac Disease |
16 |
|
Crohn Disease |
16 |
|
Cystic Fibrosis |
16 |
|
Familial Adenomatous Polyposis
(FAP) |
16 |
|
Gastro-Oesophageal Reflux Disease (GORD) |
18 |
|
Malabsorption |
18 |
|
Neoplasms |
18 |
|
Pernicious Anaemia |
19 |
|
Peutz-Jegher Syndrome |
19 |
|
Short Bowel Syndrome |
22 |
|
Ulcerative Colitis |
22 |
|
Further Reading |
23 |
1.4 |
Haematological Disease |
24 |
|
Agranulocytosis |
24 |
|
Aplastic Anaemia |
24 |
|
Bleeding Tendencies |
24 |
|
Fanconi Anaemia |
24 |
|
Haematinic Deficiency |
24 |
|
Haematopoietic Stem Cell Transplantation |
24 |
|
Haemoglobinopathies |
26 |
|
Haemolytic Disease of Newborn |
26 |
|
Haemophilia |
27 |
|
Hypereosinophilic Syndrome (HES) |
27 |
|
Hypoplasminogenaemia |
27 |
|
Leukaemias |
27 |
|
Leukocyte Defects |
29 |
|
Lymphomas |
29 |
|
Multiple Myeloma |
32 |
|
Plasmacytosis |
33 |
|
Plummer-Vinson Syndrome |
33 |
|
Polycythaemia |
35 |
|
Thrombocytopenia |
35 |
|
Von Willebrand Disease |
36 |
|
Further Reading |
36 |
1.5 |
Hepatological Disease |
38 |
|
Cirrhosis |
38 |
|
Hepatitis |
39 |
|
Jaundice |
40 |
|
Primary Biliary Cirrhosis |
40 |
|
Transplantation |
40 |
|
Further Reading |
40 |
1.6 |
Iatrogenic Conditions |
41 |
|
Haematopoietic Stem Cell Transplantation |
41 |
|
Graft-Versus-Host Disease |
41 |
|
Organ Transplantation |
41 |
|
Pharmacotherapy |
46 |
|
Chemotherapy |
46 |
|
Immunosuppressive Agents |
46 |
|
Tetracyclines |
46 |
|
Other Drugs |
46 |
|
Osteonecrosis of the Jaws (ONJ; Osteochemonecrosis) |
47 |
|
Radiotherapy |
52 |
|
Osteoradionecrosis |
56 |
|
Surgery |
56 |
|
Dry Socket (Alveolar Osteitis) |
56 |
|
Oroantral Fistula |
59 |
|
Oronasal Fistula |
59 |
|
Dental Materials |
60 |
|
Further Reading |
60 |
1.7 |
Immunodeficiencies |
62 |
|
Acatalasia |
62 |
|
Ataxia Telangiectasia |
62 |
|
Chronic Mucocutaneous Candidosis |
62 |
|
Autoimmune Polyendocrinopathy-Candidosis-Ectodermal Dystrophy |
62 |
|
Common Variable Immunodeficiency |
62 |
|
Di George Syndrome |
62 |
|
Hereditary Angioedema |
62 |
|
Human Immunodeficiency Virus Disease and Acquired Immune Deficiency Syndrome |
64 |
|
Hyper-IgM Syndromes |
73 |
|
Leukocyte Defects |
73 |
|
Myeloperoxidase Deficiency |
73 |
|
Neutropenias |
74 |
|
Papillon-Lefevre Syndrome |
74 |
|
Selective IgA Deficiency |
74 |
|
Severe Combined Immunodeficiency |
74 |
|
Sex-Linked Agammaglobulinaemia |
74 |
|
T-Cell Immune Defects |
74 |
|
Wiskott-Aldrich Syndrome |
75 |
|
Further Reading |
75 |
1.8 |
Infections |
76 |
|
Aspergillosis |
76 |
|
Blastomycosis |
76 |
|
Candidosis |
76 |
|
Cat Scratch Disease |
76 |
|
Coxsackie and Echo |
76 |
|
Cytomegalovirus (CMV) |
76 |
|
Epstein-Barr Virus (EBV) |
76 |
|
Gonorrhoea |
78 |
|
Herpes Simplex Virus (HSV) |
78 |
|
Herpes Varicella Zoster |
83 |
|
Histoplasmosis |
86 |
|
HIV |
86 |
|
Human Herpesvirus 6 (HHV-6) |
87 |
|
Human Papillomavirus (HPV) |
87 |
|
Impetigo |
87 |
|
Kaposi Sarcoma Herpesvirus (KSHV) |
87 |
|
Kawasaki Disease |
88 |
|
Leishmaniasis |
88 |
|
Leprosy |
88 |
|
Lyme Disease |
89 |
|
Measles |
89 |
|
Mucormycosis |
90 |
|
Mumps |
90 |
|
Paracoccidioidomycosis |
90 |
|
Rubella |
91 |
|
Syphilis |
91 |
|
Toxoplasmosis |
91 |
|
Tuberculosis |
91 |
|
Further Reading |
93 |
1.9 |
Mental Disease |
94 |
|
Anorexia Nervosa |
94 |
|
Anxiety States |
94 |
|
Attention Deficit Hyperactivity Disorders |
94 |
|
Autism |
96 |
|
Bulimia |
96 |
|
Depression |
96 |
|
Down Syndrome |
97 |
|
Learning Impairment |
97 |
|
Munchausen Syndrome |
97 |
|
Obsessive Compulsive Disorder |
98 |
|
Schizophrenia |
98 |
|
Substance Abuse |
98 |
|
Further Reading |
99 |
1.10 |
Mucosal, Cutaneous
and Mucocutaneous Disease |
100 |
|
Acanthosis Nigricans |
100 |
|
Allergies |
100 |
|
Behçet Syndrome (BS) |
100 |
|
Darier Disease |
101 |
|
Dermatitis Herpetiformis |
102 |
|
Dermatomyositis |
102 |
|
Dyskeratosis Congenita |
102 |
|
Ectodermal Dysplasia |
103 |
|
Eosinophilic Ulcer (EU) |
103 |
|
Epidermolysis Bullosa |
103 |
|
Erythema Multiforme |
104 |
|
Gorlin Syndrome |
109 |
|
Lichen Sclerosis |
111 |
|
Lichen Planus (LP) |
111 |
|
Linear IgA Disease (LAD) |
121 |
|
Pachyonychia Congenita |
121 |
|
Pemphigoid |
121 |
|
Pemphigus |
124 |
|
Psoriasis |
129 |
|
White Sponge Naevus |
129 |
|
Further Reading |
131 |
1.11 |
Neoplastic Disease |
133 |
|
Bone Neoplasms |
133 |
|
Langerhans Histiocytosis |
133 |
|
Leukaemia |
133 |
|
Lipoma |
133 |
|
Lymphoma |
133 |
|
Melanoma |
133 |
|
Metastases |
133 |
|
Myxoma |
133 |
|
Neuroblastoma |
133 |
|
Neurofibroma |
133 |
|
Neuroma |
133 |
|
Odontogenic Neoplasms |
135 |
|
Oral Carcinoma |
135 |
|
Osteoma |
135 |
|
Paraneoplastic Syndromes |
136 |
|
Salivary Neoplasms |
136 |
|
Sarcomas |
139 |
|
Further Reading |
140 |
1.12 |
Nephrological Disease |
142 |
|
Chronic Renal Failure |
142 |
|
Nephrotic Syndrome |
142 |
|
Oculocerebrorenal Syndrome |
142 |
|
Renal Rickets |
142 |
|
Renal Transplantation |
142 |
|
Further Reading |
143 |
1.13 |
Neurological Disease |
145 |
|
Abducens (Sixth Cranial) Nerve Palsy |
145 |
|
Alzheimer Disease |
145 |
|
Bulbar Palsy |
145 |
|
Cerebral Palsy (CP) |
145 |
|
Cerebrovascular Accident |
145 |
|
Choreoathetosis |
147 |
|
Cranial Neuropathies |
147 |
|
Down Syndrome |
147 |
|
Encephalopathies |
147 |
|
Epilepsy |
148 |
|
Facial Palsy |
149 |
|
Horner Syndrome |
149 |
|
Hypoglossal Nerve Palsy |
149 |
|
Multiple Sclerosis |
149 |
|
Neck-Tongue Syndrome |
149 |
|
Neurofibromatosis (NF) |
150 |
|
Neurosyphilis |
150 |
|
Oculomotor Nerve Palsy |
151 |
|
Parkinson Disease |
151 |
|
Sturge-Weber Syndrome |
151 |
|
Trigeminal Neuralgia |
151 |
|
Trigeminal Sensory Loss |
151 |
|
Trochlear Nerve Palsy |
152 |
|
Tuberous Sclerosis |
152 |
|
Further Reading |
153 |
1.14 |
Respiratory Disease |
155 |
|
Antral Carcinoma |
155 |
|
Asthma |
155 |
|
Cystic Fibrosis (CF) |
155 |
|
Lung Cancer |
155 |
|
Sarcoidosis |
155 |
|
Sinusitis |
155 |
|
Tonsillitis |
157 |
|
Transplantation |
158 |
|
Tuberculosis |
158 |
|
Wegener Granulomatosis |
159 |
|
Further Reading |
159 |
1.15 |
Rheumatological and Musculoskeletal Disease |
160 |
|
Cherubism |
160 |
|
Cleidocranial Dysostosis |
160 |
|
Craniofacial Dysostosis |
160 |
|
Connective Tissue Diseases |
160 |
|
Ehlers-Danlos Syndrome |
160 |
|
Ellis-van Creveld Syndrome |
160 |
|
Fibrous Dysplasia |
160 |
|
Lupus Erythematosus |
160 |
|
Mandibulofacial Dysostosis |
160 |
|
Myasthenia Gravis |
160 |
|
Mixed Connective Tissue Disease |
160 |
|
Osteogenesis Imperfecta |
160 |
|
Osteopetrosis |
160 |
|
Paget Disease of Bone |
161 |
|
Reactive Arthritis |
163 |
|
Rheumatoid Arthritis |
163 |
|
Scleroderma |
164 |
|
Sjögren Syndrome |
165 |
|
Further Reading |
175 |
2 |
Common and important
Disorders Affecting Maxillofacial Region: Differential Diagnosis by Site |
177 |
|
Diagnosis |
177 |
|
Investigations |
177 |
2.1 |
Lips |
179 |
|
Aesthetic Conditions |
179 |
|
Blisters |
186 |
|
Pigmented, Red, Purple or Blue Lesions |
189 |
|
Soreness, Ulceration and Pain |
193 |
|
Swellings and Lumps |
202 |
|
White Lesions |
204 |
|
Further Reading |
208 |
2.2 |
Oral Mucosa |
210 |
|
Aesthetic Conditions |
210 |
|
Blisters |
210 |
|
Pigmented, Red, Purple or Blue Lesions |
210 |
|
Soreness, Ulceration and Pain |
215 |
|
Swellings and Lumps |
222 |
|
White Lesions |
226 |
|
Further Reading |
236 |
2.3 |
Tongue |
239 |
|
Aesthetic Conditions |
239 |
|
Congenital Conditions |
239 |
|
Pigmented, Red, Purple or Blue Lesions |
243 |
|
Soreness, Ulceration and Pain |
247 |
|
Swellings and Lumps |
250 |
|
White Lesions |
256 |
|
Further Reading |
260 |
2.4 |
Palate and Fauces |
262 |
|
Aesthetics |
262 |
|
Blisters |
262 |
|
Red, Purple or Blue Lesions |
262 |
|
Soreness, Ulceration and Pain |
268 |
|
Swellings and Lumps |
271 |
|
White Lesions |
272 |
|
Further Reading |
278 |
2.5 |
Gingivae and Periodontal Tissues |
279 |
|
Aesthetic Conditions |
279 |
|
Bleeding |
279 |
|
Blisters |
281 |
|
Gingival Attachment Loss |
281 |
|
Pigmented, Red, Purple or Blue Lesions |
283 |
|
Soreness, Ulceration and Pain |
287 |
|
Swellings and Lumps |
289 |
|
White Lesions |
293 |
|
Further Reading |
297 |
2.6 |
Neck |
300 |
|
Skin and Fascia |
300 |
|
Lymph Nodes |
300 |
|
Lymph Node Swelling |
302 |
|
Other Lesions in the Neck |
306 |
|
Further Reading |
307 |
2.7 |
Salivary Glands |
308 |
|
History Related to Salivary Problems |
308 |
|
Diagnosis |
308 |
|
Investigations |
308 |
|
Drooling |
309 |
|
Dry Mouth |
309 |
|
Sjögren Syndrome |
311 |
|
Swellings and Lumps |
311 |
|
Sarcoidosis |
315 |
|
Sialosis (Sialadenosis) |
322 |
|
Sjögren Syndrome |
323 |
|
Further Reading |
323 |
2.8 |
Jaws |
324 |
|
History Related to Jaw Problems |
324 |
|
Diagnosis |
324 |
|
Jaw Anatomical and Morphological Defects and Non-Odontogenic Cystic Lesions |
325 |
|
Jaw Pain |
326 |
|
Jaw Swellings |
329 |
|
Further Reading |
342 |
2.9 |
Temporomandibular Joint Disorders |
344 |
|
Mandibular Pain-Dysfunction Syndrome
[Temporomandibular
Joint (TMJ)
Dysfunction Syndrome] |
344 |
|
Temporomandibular Ankylosis |
345 |
|
Temporomandibular Joint Subluxation |
345 |
|
Further Reading |
346 |
2.10 |
Teeth |
347 |
|
History Related to Dental Problems |
347 |
|
Dental Examination |
347 |
|
Diagnosis |
348 |
|
Aesthetics |
348 |
|
Early Tooth Loss |
356 |
|
Eruption Disorders |
356 |
|
Tooth Number Variations |
359 |
|
Tooth Size, Shape and Structural Anomalies |
361 |
|
Tooth Surface Loss |
367 |
|
Further Reading |
372 |
2.11 |
Maxillofacial Neurological Disorders and Pain |
374 |
|
History Related to Pain and Neurological Problems |
374 |
|
General Features |
374 |
|
Sensory System |
374 |
|
Motor System |
374 |
|
Cranial Nerve Examination |
375 |
|
Diagnosis |
376 |
|
Investigations |
376 |
|
Involuntary Movements |
377 |
|
Pain |
379 |
|
Paralysis in the Maxillofacial Region |
382 |
|
Sensory Loss in the Maxillofacial Region |
385 |
|
Further Reading |
389 |
3 |
Differential Diagnoses and Management |
391 |
3.1 |
Differential
Diagnoses by Symptoms or Signs |
393 |
3.2 |
Differential
Diagnoses by Site |
405 |
3.3 |
Guide to
the Diagnosis and Management of Orofacial Diseases |
412 |
3.4 |
Guide to
Drugs Used in the Management of Orofacial
Diseases |
428 |
3.5 |
Guide to
the Orofacial
Adverse Effects of Drug Treatment |
443 |
|
Index |
451 |
|
|
|